Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,199
Closed -$745K 456
2023
Q2
$745K Sell
9,199
-1,673
-15% -$137K 0.44% 92
2023
Q1
$877K Sell
10,872
-1,490
-12% -$120K 0.48% 63
2022
Q4
$925K Buy
12,362
+2,910
+31% +$207K 0.48% 15
2022
Q3
$610K Buy
+9,452
New +$655K 0.24% 167
2018
Q3
Sell
-516
Closed -$21K 350
2018
Q2
$21K Hold
516
0.02% 203
2018
Q1
$19K Hold
516
0.02% 194
2017
Q4
$22K Buy
+516
New +$20.6K 0.03% 179

Other funds holding HOLX

Virtus ETF Advisers's HOLX Position: Q3 2023 in Review

Virtus ETF Advisers sold out of Hologic (HOLX) in Q3 2023, closing a stake of 9,199 shares — an estimated $745K sold.

Virtus ETF Advisers first reported a position in HOLX in Q4 2017 and held it in 7 quarters. The position peaked at $925K in Q4 2022. 692 funds tracked by Wall St. Rank hold HOLX as of Q3 2023.

  • Virtus ETF Advisers reported no remaining Hologic position as of Q3 2023 after selling out during the quarter.
  • Virtus ETF Advisers sold 9,199 Hologic shares in Q3 2023, an estimated $745K.
  • Virtus ETF Advisers first reported a position in Hologic in Q4 2017 and held it in 7 quarters.
  • Virtus ETF Advisers's Hologic position peaked at $925K in Q4 2022.
  • 692 funds tracked by Wall St. Rank held Hologic as of Q3 2023.

Based on Virtus ETF Advisers's 13F filing for Q3 2023, filed 7 Nov 2023.